Google News – Clinical Trials External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Google News – Biopharma External News
Alumis’ TYK2 drug fails in key lupus study - BioPharma Dive
Google News – Pharmaceuticals External News
INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. (REGN) Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit Before September 14, 2026 Deadline - prnewswire.com
Google News – Biopharma External News
Why CMC readiness is becoming central to biopharma licensing deals - Clinical Trials Arena
Google News – Biopharma External News
Korea's GC Biopharma collaborates with French firm Osivax to develop next-gen influenza vaccine - BioSpectrum Asia
Google News – Biopharma External News
Mid-cap biotechs join Trump’s latest round of drug pricing deals - BioPharma Dive
Google News – Pharmaceuticals External News
Trump cuts deals to exempt pharmaceutical companies from tariffs - KGW
Google News – Biopharma External News
Novartis says MS pill succeeds in two large studies - BioPharma Dive
Google News – Pharmaceuticals External News
President Trump announces new pharmaceutical deals: KNOE8 Streaming News 9/1/2026 - KNOE
Google News – Pharmaceuticals External News
Beyond the Patent Cliff: Why Generics and Biosimilars Demand Different Playbooks - Pharmaceutical Commerce
Industry News External News
Aurobindo Pharma arm Apitoria incorporates Avogent Lifesciences as subsidiary - The Times of India
Google News – FDA (biotech/pharma) External News
FDA approves Besremi, a treatment for essential thrombocythemia - The Pharma Letter
Google News – Pharmaceuticals External News
Crinetics Pharmaceuticals, Inc. SEC Filing (Sep 1, 2026) - Stock Titan
Google News – FDA (biotech/pharma) External News